Brouwer Niels J, Marinkovic Marina, Luyten Gregorius P M, Shields Carol L, Jager Martine J
Department of Ophthalmology, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.
Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA.
Graefes Arch Clin Exp Ophthalmol. 2019 Aug;257(8):1783-1788. doi: 10.1007/s00417-019-04342-x. Epub 2019 May 16.
In primary conjunctival melanoma (CoM), one of the characteristics that is associated with an increased risk of metastases and death is a lack of tumour pigmentation. The aim of this study was to investigate whether the degree of pigmentation of CoM recurrences relates similarly to clinical outcome.
A data set of 177 patients with a CoM recurrence from the Wills Eye Hospital (USA) and the Leiden University Medical Center (The Netherlands) was analysed. The relation between clinical tumour pigmentation of the recurrences, the characteristics of the primary lesions and clinical outcome was investigated.
In 117 (66%) of 177 patients with a CoM recurrence, tumour pigmentation was known: 71 patients (61%) had recurrences with low pigmentation. Primary lesions had low pigmentation in 39% of cases, which is significantly different (p = 0.001). However, low tumour pigmentation of recurrences correlated with low tumour pigmentation of the primary lesion (p < 0.001). No association was observed between pigmentation of the recurrences and iris colour (p = 0.66). Low pigmentation of the recurrences was not significantly associated with an increased risk for metastases (HR 1.96, p = 0.12) or death (HR 1.79, p = 0.27), whereas primary tumours with low pigmentation did show a greater risk for metastases (HR 2.82, p = 0.016) and death (HR 2.90, p = 0.037).
CoM recurrences are more often lightly pigmented compared to primary lesions. A correlation exists between the degree of pigmentation of primary and recurrent lesions, but recurrences can appear with any degree of pigmentation. Unlike primary CoM, the level of pigmentation of CoM recurrences is not related to metastasis or death.
在原发性结膜黑色素瘤(CoM)中,与转移和死亡风险增加相关的特征之一是缺乏肿瘤色素沉着。本研究的目的是调查CoM复发的色素沉着程度是否与临床结局有类似的关联。
分析了来自美国威尔斯眼科医院和荷兰莱顿大学医学中心的177例CoM复发患者的数据集。研究了复发的临床肿瘤色素沉着、原发性病变特征与临床结局之间的关系。
在177例CoM复发患者中,有117例(66%)的肿瘤色素沉着情况已知:71例患者(61%)复发时色素沉着较低。原发性病变在39%的病例中色素沉着较低,这有显著差异(p = 0.001)。然而,复发时肿瘤色素沉着低与原发性病变的肿瘤色素沉着低相关(p < 0.001)。未观察到复发的色素沉着与虹膜颜色之间存在关联(p = 0.66)。复发时色素沉着低与转移风险增加(风险比1.96,p = 0.12)或死亡风险增加(风险比1.79,p = 0.27)无显著关联,而色素沉着低的原发性肿瘤确实显示出更高的转移风险(风险比2.82,p = 0.016)和死亡风险(风险比2.90,p = 0.037)。
与原发性病变相比,CoM复发时色素沉着较轻的情况更为常见。原发性和复发性病变的色素沉着程度之间存在相关性,但复发可出现任何色素沉着程度。与原发性CoM不同,CoM复发的色素沉着水平与转移或死亡无关。